Kae Capital, an early-stage investing firm in India, has closed its Winners Fund II (KWF II), raising $50 million.

Kae Capital said in a statement on Thursday that some of the key investors who have invested in this fund are Velo Partners, Henry Kravis (Co-Founder and Co-Executive Chairman, KKR), 360 ONE (formerly IIFL Wealth & Asset Management), Prashant Tandon & Tanmay Saksena (Co-Founder/Chief Executive Officer and Chief Operating Officer, Tata 1MG), Sameer Maheshwari (Founder, HealthKart), Abhay Soi (Founder, Max Healthcare), Hemendra Kothari (Founder, DSP Group), Yogesh Agrawal (Managing Director, Ajanta Pharma), Sanket & Apurva Parekh (Pidilite), and VM Thapar Family Office.

Like all the previous funds, KWF II was oversubscribed.

It is noted that Kae Capital has been investing in India for more than a decade now.

It is a sector-agnostic fund that invests in pre-seed to pre-series A stages of a company’s lifecycle.

Its typical initial cheque sizes range between $1 million to $3 million.

Kae is an early-stage investor in many leading companies such as Porter, Zetwerk, HealthKart, Nazara, and Tata 1MG, among others.

It has invested in 81 startups, with a portfolio enterprise valuation of $8.76 billion and has made 14 exits.

Through KWF II, Kae is targeting to invest in 20 companies.

Contrary to its regular funds, KWF II offers exclusive access to companies of previous funds that are leaders in their respective markets, thus allowing co-investment with growth-stage funds in Series B, C and D rounds.

In addition to its own portfolio, the fund gives Kae the opportunity to invest in other market-leading companies.

Some of the companies it has already invested in from this fund are HealthKart, Wysa, Brightchamps and Disprz.

“We are delighted to announce the closure of Kae Winners Fund II. Being pioneers of early-stage investing in India, we’ve seen the ecosystem grow and see enough merit in being involved for as long as possible in a company’s lifecycle,

“We have launched this fund in order to continue backing our best founders, alongside other successful founders in the ecosystem, who are not yet a part of the Kae family,” said Sasha Mirchandani, Partner of Kae Capital.

Kae Capital is a pioneer of early-stage investing in India, focused on tech startups, and has been investing in India for 10+ years.

Founded in 2012, with offices in Mumbai and Bengaluru, Kae is a sector-agnostic fund that invests in pre-seed to pre-series A.

Kae partners with passionate founders and teams, building for Indian and global markets.

The firm aims to be an all-weather partner to its portfolio founders, enabling them to build enduring companies.

Kae has a portfolio enterprise valuation of $8.76 billion, having invested in 81 startups. Its portfolio has a mix of business to business (B2B) and business to consumer (B2C) startups.

Some of the marquee names are Tata 1MG (health tech), Porter (logistics tech), Nazara Technologies (gaming), HealthKart (health tech), Zetwerk (manufacturing tech), Wysa (health tech), Square Yards (property tech), and Disprz (e-learning).

Kae is the first institutional investor in a majority of its portfolio companies.

India’s Kae Capital announces the final close of Fund III at $96M